Workday and GenesisCare
Sydney-headquartered GenesisCare delivers treatment to people with cancer and heart disease, the two largest global disease burdens. It is committed to leading the change in how care is given and is currently leading or participating in more than 150 clinical trials. The organization employs more than 5,500 highly trained physicians, healthcare professionals, and support staff across Australia, Europe, and now the U.S. This follows its acquisition of major U.S.-integrated oncology provider 21st Century Oncology in May 2020.